Public Meeting Notice

Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — March 6, 2025

Thursday, March 6, 2025 at 8:00 a.m.
Posted: February 7, 2025 3:30 p.m.

Overview

This meeting will be by Webex Conference Call.

Join by the webinar number

  • Webinar number (access code):  2538 954 1048
  • Webinar password: BOP123 (267124 from phones and video systems) 

Join by telephone

  • +1-617-315-0704 United States Toll (Boston)
  • +1-650-479-3208 United States Toll

If you need reasonable accommodations in order to participate in the meeting, contact the DPH ADA Coordinator Erin Bartletterin.bartlett2@mass.gov or 857-262-7431 in advance of the meeting. While the Board will do its best to accommodate you, certain accommodations may require distinctive requests or the hiring of outside contractors and may not be available if requested immediately before the meeting.      

Agenda

TimeItem #Item
8:00ICALL TO ORDER
8:05IIAPPROVAL OF AGENDA
8:10III

APPROVAL OF BOARD MINUTES

  • Draft of February 6, 2024, Regular Session Minutes
8:15IV

REPORTS

  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation     
  • Board Delegated Review pursuant to Licensure Policy 14-02
8:20V

FLEX

  • Board member changes
  • NABP annual meeting election of delegates
  • Guaifenesin with Codeine Memo
  • Licensing Update
  • Open Meeting Law- 940 CMR 29.00
8:45VI

POLICIES

  • Policy 14-02: Board Delegated Review (BDR)
9:00VII

EMERGENCY AMENDMENTS TO REGULATIONS TO IMPLEMENT SHIELD LAW

  • 247 CMR 3.00: Pharmacist Licensure Requirements
  • 247 CMR 6.00: Licensure of Pharmacies
  • 247 CMR 8.00: Pharmacy Interns and Technicians 
  • 247 CMR 10.00: Disciplinary Proceedings 
9:10VIII

REVIEW OF COMPLIANCE/VIOLATION OF CONSENT AGREEMENT

  • Carbone, Domenico PH16514 – Docket No PHA-2023-0142
9:20IX

APPLICATION

  • Vantive US Healthcare LLC – New Retail Pharmacy
  • Option Care – Sterile Compounding License
  • Revive Rx (NDSNE97431SC) Sterile Compounding License - New Application
  • Galaxy Pharmacy; DS90257- Relocation
10:00X

FILE REVIEW

1CASE-2024-3749INV15492Grant LaPierre, PH239985
2CASE-2024-2654PHA-2024-0174Medwiz of Mass, LLC, DS90404 
3CASE-2024-3753PHA-2025-0007Kenny Correia, PH232913
4CASE-2024-2625PHA-2024-0176Genoa Healthcare LLC, DS90412
5CASE-2024-2823PHA-2024-0184Springfield Pharmacy, DS90286
6CASE-2024-2827PHA-2024-0189Walmart 10-5448, DS89911
7CASE-2024-3186PHA-2024-0214Walgreens #4729, DS2878
8CASE-2024-3051PHA-2024-0197Prescription Center Pharmacy, DS89916
9CASE-2025-0282PHA-2025-0018ProRx, LLC, NO10087
10CASE-2024-2559PHA-2024-0169Walgreens #10401, DS3553
11CASE-2024-2697PHA-2024-0172Southcoast Pharmacy, DS89872
12CASE-2024-2499PHA-2024-0159Wal-Mart 10-2903, DS2966
13CASE-2024-2499PHA-2024-0160Deepa Singh, PT15474
14CASE-2024-2496PHA-2024-0164CVS #1015, DS1534
11:00XI

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant. The

12:00XIIADJUDICATORY SESSION (M.G.L. ch. 30A, §18)
12:15 LUNCH BREAK
12:45XIIIM.G.L. c. 112, § 65C SESSION
3:00XIVADJOURNMENT

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback